Latest Breaking News On - National health insurance research database of taiwan - Page 1 : comparemela.com

Patients with lupus at highest risk for ischemic heart disease 6 to 9 years post-diagnosis

GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis

Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients.

GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis

In adults with cirrhosis and type 2 diabetes, glucagon-like peptide-1 receptor agonist therapy significantly lowered the risk for death and other adverse outcomes, a study found.

GLP-1 Drugs Linked to Survival in Type 2 Diabetes With Renal Disease

Real-world comparison with DPP-4 inhibitors adds to evidence differentiating the two classes

Fewer Diabetic Complications Seen When NOACs Given for AF

While the conclusions fit with those of RCTs, one expert says some of the outcome data should be taken “with a grain of salt.”